The cord blood banking industry is one of the fastest growing industries in the world. There were only 23 active cord blood banks as of 2005, and now there are 485 worldwide. Cord blood banks now exist in nearly every developed country, as well as within several developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry in less than a ten year period.
Within the United States, cord blood banks have appeared in nearly every state. Furthermore, the U.S. cord blood banking industry is the most mature cord blood banking market in the world, having the:
This rapid market growth represents both an opportunity to profit, as well as swarming competition.
The field of cord blood banking is a fast-growth field, driven by medical necessity and consumer demand. It is also a recent industry, as it was not until 1974 that it was first proposed that stem and progenitor cells were present in human cord blood and 1983 that umbilical cord blood was proposed as an alternative source of stem cells for transplant. In 1988, the first successful cord blood transplant occurred, but it was not until 1995 that the first private cord blood bank began operations.
Furthermore, it was not until July 2010, when the Cord Blood Registry became the first private U.S. cord blood bank to offer umbilical cord tissue storage. In the two years that have since passed, the number of private U.S. cord blood banks offering cord tissue storage has risen to nine. This represents an average of one new U.S. cord blood bank adding cord tissue storage every three months. If this rate continues, half of all private U.S. cord blood banks will offer cord tissue storage within two years.
Since the first cord blood transplant was performed in 1988, stem cells derived from umbilical blood have been used in more than 30,000 transplants worldwide to treat a wide range of blood diseases, genetic and metabolic disorders, immunodeficiencies and various forms of cancer. However, there is still significant variation within the industry. There is the divide between private and public cord blood banking, in which private companies serve individual families, while public banks serve the broader public. Additionally, some cord blood banks receive only units from nearby hospitals and birthing centers, while others allow mail-in units from a wide geographic region.
There is also variation in the services offered by private cord blood banks, as some companies only offer cord blood storage only and others offer it in conjunction with cord tissue storage. Finally, there is also significant variation in the quality, pricing and guarantees promised by cord blood banks.
In this comprehensive industry report, you'll learn:
Part 1: U.S. Cord Blood Banking Industry - Market Overview & Outlook
The first section of the report “roots” where the cord blood banking industry has been, what has shaped it, and where it is going. Using both qualitative and quantitative assessment, it explores critical timeline events, current and future conditions treatable, advantages of cord blood transplant, probabilities of requiring stem cell transplant throughout the lifespan, and more. With this detailed knowledge, you can know the relative strength of your position within the marketplace.
Part 2:Expansion and Growth - Trailing 12-Month Analysis & Forward Projections
The second section explores where the U.S. cord blood banking industry is now and what you should anticipate for the near-term future, based on recent trends and five-year projections. Critically, it explores strategies of fast-growth U.S. companies and compares their actions and attributes to slow-growth companies, providing a comprehensive road-map to industry dominance.
Furthermore, detailed assessment of U.S. cord blood industry trends are presented in this section, including:
Part 3: Comprehensive Parent Survey - Continuing to Grow by Listening to Expectant Parents
While the last section showed you what to expect if trends continue as they are and revealed the environment that you will find yourself in within the next five years, this final section is your guide to taking strategic action and controlling your competitive position.
This section contains findings from a detailed survey that reveals how U.S. parents learn about cord blood banking, think about the process, and make key decisions. This survey is your insight into the mind of your prospective clients. Key findings from the survey include how to:
In summary, this section is your guide to growing, expanding, and profiting, by listening to the needs of your clients - expectant parents within the U.S.
Over the past 12 months, the cord blood banking industry has expanded through double digit growth, due to new entrants in the cord blood banking industry, as well as revenue growth at existing operations.
To guide industry competitors, this report carefully considers the following questions:
Deeper analysis also reveals that existing cord blood banks follow a bi-modal distribution, either experiencing flat-line growth (less than 3% per annum) or substantively building revenue (25% or more per annum).
While a similar bimodal distribution existed in the prior 12 month period (trailing 12 to 24 months), the peaks have continued to separate over the past 12 months, with the average flat-growth company staying stagnant and the average revenue growth company increasing its per annum growth rate from 17% per year to 25% per year. This trend indicates an increasing shift in dominance toward fast-growth companies, which begs the questions:
As mentioned above, this industry report is a comprehensive road-map for operating a successful cord blood bank. It takes you from the where the industry has been, to where it is now, to where is is going in the next five years. In addition, it gives you insider knowledge of how expectant parents think, so you can get there fast.
It teaches you - management of a private cord blood bank - how to strategically position your services to increase market share and attract expectant parents to your company.
Rather than focusing on the “medical” and “technical” aspects of cord blood stem cells, the report focuses on the practical and strategic applications necessary to successfully run a private cord blood bank. While the medical angle is interesting, you already know that part of your business. It would tell you nothing about strategic actions to take to have more expectant parents purchasing services from you, instead of the competition.
Instead, this industry report is focused on your needs and includes content relevant to what you want to know - how to optimally price your services, criteria that make expectant parents likely to purchase private cord blood banking services, and how to grow in a competitive industry.
Like it or not, the cord blood banking industry is getting more and more competitive every day. By doing nothing, clients will likely be won over by better informed, or simply more aggressive, competitors.
BioInformant only produces stem cell industry data. Because stem cells are richly populated in cord blood, we have been tracking the cord blood industry since 2005, when it was an early stage market. Unlike BioInformant, other publishers of cord blood data are broad range publishers without expertise in any specific area - this limits their ability to produce exactly what you need.
We understand the nuances of your business, because we have been analyzing your industry since 2005.
When we started tracking the cord blood banking industry seven years ago there were only 23 active cord blood banks. There are now 485 worldwide. That is a 21-fold increase (2,100%) in the number of companies involved within this industry in less than a ten-year period.
Within the United States, there are now 70 active public and private cord blood banks, spread across nearly every U.S. state.
Understanding the drastic increase in the quantity of competition makes it clear why you would benefit from the trends, market intelligence, and industry data in this report.
We track this cord blood banking industry meticulously, year-after-year producing more revealing and accurate data. With great interest, we have annually identified the most successful industry participants and done careful study of the commonalities that exist among this group. We treat these companies as “models” for successful cord blood banking operation.
With equally great interest, we have also annually identified the least successful cord blood companies and done careful study to identify the commonalities that exist among this group. We treat these companies as “warnings” for how to not operate a cord blood bank, unless the goal is to run it into the ground.
In this report, we present our detailed findings for your benefit - we give you the road-map for how to be a fast-growth cord blood bank, so you can avoid the fate of a flat-growth company.
Our historical knowledge of the cord blood industry also means that we have seven years of trailing data on the industry, and are therefore, are optimally positioned to provide you with forward projections for the industry.
While no one can predict the future with 100% certainty, our foundation of knowledge means that we have the greatest likelihood of accurately predicting future trends and growth within the cord blood banking industry.
We are the only producer of data specific for cord blood banks that actually teaches you how to effectively sell your services, strategically position your products, and make more money.
In a cut-throat industry, you need to access the tools that you competition already has. Because BioInformant has been the leading supplier of cord blood industry data since 2005, we have already served most of the world's leading private cord blood banks.
Existing clients of ours include: The Virgin Health Bank, Canadian Blood Services, Cryo-Save AG, Insception Cord Blood Bank, StemCyte Inc., The New York Blood Center, Xytex Corporation, Cells For Life, SmartBank, NHS Cord Blood Bank (NHBTS), Secuvita, Eurocord, Neostem, Cord Life Singapore, Thermogenesis, Biosafe SA, Cryo-Save, The Till Group, Precious Cells, the National Marrow Donor Program (NMDP), and many more.
While our sole focus has been on producing high quality market intelligence targeted for head management of private cord blood banks, we were surprised to find that a range of other companies also require reputable, accurate, and substantiated data for the cord blood industry.
These companies either expect to launch cord blood banking services, are interested in investing in companies within the cord blood industry, or they are interested in selling services to cord blood facilities. To this end, we often serve biotech venture capitalists, strategic consultancy companies, and healthcare organizations.
Other companies in the cord blood industry have already claimed this report and are implementing actions based on it. Can you afford to let them have that edge in an industry that has grown 21-times more competitive over the past seven years?
This is the only cord blood industry market report available that includes direct insight (survey results) into the minds of expectant parents - your clients. We have interviewed more than 567 U.S. expectant parents in order to understand how they view cord blood banking services.
We have explored how they perceive the benefits and drawbacks, how they describe their fears and motivations, and how they describe the decision-making process. We have captured this invaluable insight for you in Section 3 of the report - "Comprehensive Parent Survey - Continuing to Grow by Listening to Expectant Parents (567 Respondents)".
Browse more Regenerative Medicine Market Research Reports